Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress

  • Andrzej Slominski
    Department of Pathology, Loyola University Medical Center, Maywood; Department of Medicine, Southern Illinois University, Springfield, Illinois; Department of Dermatology, Ludwig Boltzmann Institute of Cell Biology and Immunobiology of the Skin, University of Munster, Munster; Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany; and Department of Medicine and Biochemistry, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada
  • Jacobo Wortsman
    Department of Pathology, Loyola University Medical Center, Maywood; Department of Medicine, Southern Illinois University, Springfield, Illinois; Department of Dermatology, Ludwig Boltzmann Institute of Cell Biology and Immunobiology of the Skin, University of Munster, Munster; Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany; and Department of Medicine and Biochemistry, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada
  • Thomas Luger
    Department of Pathology, Loyola University Medical Center, Maywood; Department of Medicine, Southern Illinois University, Springfield, Illinois; Department of Dermatology, Ludwig Boltzmann Institute of Cell Biology and Immunobiology of the Skin, University of Munster, Munster; Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany; and Department of Medicine and Biochemistry, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada
  • Ralf Paus
    Department of Pathology, Loyola University Medical Center, Maywood; Department of Medicine, Southern Illinois University, Springfield, Illinois; Department of Dermatology, Ludwig Boltzmann Institute of Cell Biology and Immunobiology of the Skin, University of Munster, Munster; Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany; and Department of Medicine and Biochemistry, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada
  • Samuel Solomon
    Department of Pathology, Loyola University Medical Center, Maywood; Department of Medicine, Southern Illinois University, Springfield, Illinois; Department of Dermatology, Ludwig Boltzmann Institute of Cell Biology and Immunobiology of the Skin, University of Munster, Munster; Department of Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg, Germany; and Department of Medicine and Biochemistry, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada

書誌事項

公開日
2000-07-01
DOI
  • 10.1152/physrev.2000.80.3.979
公開者
American Physiological Society

この論文をさがす

説明

<jats:p>The skin is a known target organ for the proopiomelanocortin (POMC)-derived neuropeptides α-melanocyte stimulating hormone (α-MSH), β-endorphin, and ACTH and also a source of these peptides. Skin expression levels of the POMC gene and POMC/corticotropin releasing hormone (CRH) peptides are not static but are determined by such factors as the physiological changes associated with hair cycle (highest in anagen phase), ultraviolet radiation (UVR) exposure, immune cytokine release, or the presence of cutaneous pathology. Among the cytokines, the proinflammatory interleukin-1 produces important upregulation of cutaneous levels of POMC mRNA, POMC peptides, and MSH receptors; UVR also stimulates expression of all the components of the CRH/POMC system including expression of the corresponding receptors. Molecular characterization of the cutaneous POMC gene shows mRNA forms similar to those found in the pituitary, which are expressed together with shorter variants. The receptors for POMC peptides expressed in the skin are functional and include MC1, MC5 and μ-opiate, although most predominant are those of the MC1 class recognizing MSH and ACTH. Receptors for CRH are also present in the skin. Because expression of, for example, the MC1 receptor is stimulated in a similar dose-dependent manner by UVR, cytokines, MSH peptides or melanin precursors, actions of the ligand peptides represent a stochastic (predictable) nonspecific response to environmental/endogenous stresses. The powerful effects of POMC peptides and probably CRH on the skin pigmentary, immune, and adnexal systems are consistent with stress-neutralizing activity addressed at maintaining skin integrity to restrict disruptions of internal homeostasis. Hence, cutaneous expression of the CRH/POMC system is highly organized, encoding mediators and receptors similar to the hypothalamic-pituitary-adrenal (HPA) axis. This CRH/POMC skin system appears to generate a function analogous to the HPA axis, that in the skin is expressed as a highly localized response which neutralizes noxious stimuli and attendant immune reactions.</jats:p>

収録刊行物

  • Physiological Reviews

    Physiological Reviews 80 (3), 979-1020, 2000-07-01

    American Physiological Society

被引用文献 (17)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ